113 related articles for article (PubMed ID: 17878687)
21. Genetics of pulmonary arterial hypertension.
Elliott CG
Clin Chest Med; 2013 Dec; 34(4):651-63. PubMed ID: 24267296
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic pulmonary hypertension: what did we learn from genes?
Sztrymf B; Yaïci A; Jaïs X; Sitbon O; Simonneau G; Humbert M
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S91-100. PubMed ID: 16457021
[TBL] [Abstract][Full Text] [Related]
23. Neurofibromatosis-associated pulmonary hypertension: an ominous duo.
Coelho SG; Loureiro MJ
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32665279
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].
Fujiwara M; Yagi H; Matsuoka R; Saji T
Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722
[TBL] [Abstract][Full Text] [Related]
25. [Severe pulmonary involvement in the course of type 1 neurofibromatosis].
Martignac B; Gagnadoux F; Trzepizur W; Beneton N; Vinchon F; Paris A; Montani D; Goupil F
Rev Mal Respir; 2014 Sep; 31(7):621-3. PubMed ID: 25239584
[TBL] [Abstract][Full Text] [Related]
26. EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.
Eichstaedt CA; Song J; Benjamin N; Harutyunova S; Fischer C; Grünig E; Hinderhofer K
Respir Res; 2016 Nov; 17(1):141. PubMed ID: 27809840
[TBL] [Abstract][Full Text] [Related]
27. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
[TBL] [Abstract][Full Text] [Related]
28. Endothelial-to-mesenchymal transition in pulmonary hypertension.
Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
[TBL] [Abstract][Full Text] [Related]
29. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
30. The Efficacy of a Genetic Analysis of the BMPR2 Gene in a Patient with Severe Pulmonary Arterial Hypertension and an Atrial Septal Defect Treated with Bilateral Lung Transplantation.
Tatebe S; Sugimura K; Aoki T; Yamamoto S; Yaoita N; Suzuki H; Sato H; Kozu K; Konno R; Satoh K; Fukuda K; Adachi O; Saito R; Nakanishi N; Morisaki H; Oyama K; Saiki Y; Okada Y; Shimokawa H
Intern Med; 2017 Dec; 56(23):3193-3197. PubMed ID: 29021450
[TBL] [Abstract][Full Text] [Related]
31. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
32. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
[TBL] [Abstract][Full Text] [Related]
33. Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1.
Petrak B; Bendova S; Seeman T; Klein T; Lisy J; Zatrapa T; Marikova T
Neuro Endocrinol Lett; 2007 Dec; 28(6):734-8. PubMed ID: 18063929
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
[TBL] [Abstract][Full Text] [Related]
35. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW
Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546
[TBL] [Abstract][Full Text] [Related]
36. The BMPR2 missense mutation p.K230N and pulmonary arterial hypertension.
Hayes D; Ramanathan C; Kopp BT
Pediatr Pulmonol; 2014 Jan; 49(1):E5-6. PubMed ID: 23139147
[TBL] [Abstract][Full Text] [Related]
37. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
38. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary arterial hypertension associated to systemic erythematosus lupus: molecular characterization of 3 cases.
Pousada G; Lago-Docampo M; Baloira A; Valverde D
Med Clin (Barc); 2018 Aug; 151(3):111-115. PubMed ID: 29526310
[TBL] [Abstract][Full Text] [Related]
40. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
